Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals for the Smart Red Blood Cells program, which aims to engineer red blood cells with novel biological features to enhance human physiology. This program focuses on creating smart red blood cells that can sense, decide, and act to improve human performance and survival, excluding clinical trials.
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals in support of the Smart Red Blood Cells program (Smart-RBC). The DARPA Smart-RBC program aims to engineer red blood cells to contain novel biological features that can safely, temporarily, and reliably alter human physiology. Specifically, the Smart-RBC program will revolutionize blood products by creating smart red blood cells (SRBCs). SRBCs will be engineered to contain additional biological circuits consisting of three layers: Sense extracellular biomarkers; Decide next steps; Act by creating effector molecules that can alter metabolism or physiology. The program will identify the art-of-the-possible to create SRBCs to enhance human performance and maximize survival via hemostasis products. This program does not include clinical trials or direct human testing.
Smart Red Blood Cells (Smart-RBC) is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.